Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Combining Guselkumab with Upadacitinib Is Safe and Effective in the Treatment of Medically Complex Inflammatory Bowel Disease.
Journal: Digestive diseases and sciences
Published: February 12, 2026
Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays.
Journal: Expert review of gastroenterology & hepatology
Published: October 10, 2024
Low ALT levels and a new diagnosis of congestive heart failure following COVID-19 infection.
Journal: Frontiers in cardiovascular medicine
Published: July 25, 2024
Long term outcomes after COVID-19 in patients with schizophrenia: a historical cohort study in a health maintenance organization.
Journal: Social psychiatry and psychiatric epidemiology
Published: April 11, 2024
Low ALT Is Associated with IBD and Disease Activity: Results from a Nationwide Study.
Journal: Journal of clinical medicine
Published: March 04, 2024
TEN-HOUR INTERMITTENT FASTING PLUS MEDITERRANEAN DIET VERSUS MEDITERRANEAN DIET ALONE FOR TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Journal: Harefuah
Published: March 03, 2024
Pre-infection anticoagulant exposure and SARS-CoV-2 infection outcomes - Differential mortality by age.
Journal: Thrombosis research
Published: August 09, 2023
Patients with low ALT levels are at increased risk for severe COVID-19.
Journal: Frontiers in medicine
Published: May 30, 2023
Real-Life Comparison of Fosfomycin to Nitrofurantoin for the Treatment of Uncomplicated Lower Urinary Tract Infection in Women.
Journal: Biomedicines
Published: February 24, 2023
Last Updated: 09/26/2026